S1 Guideline: Impairment of gonadal function after Cancer in Childhood and Adolescence

Borgmann-Staudt A, Jantke A, Hinz S, Beckmann M, Dittrich R, Lotz L, Balcerek M (2023)

Publication Type: Journal article

Publication year: 2023

Journal

Klinische Pädiatrie Georg Thieme Verlag

DOI: 10.1055/a-2081-0605

Abstract

A possible negative consequence of cancer treatment is the fertility impairment of young cancer survivors. However, most former patients express the wish to have biological children. Fertility-preserving measures are available and are - under certain circumstances - financed by health insurance. Separate information at the time of diagnosis and during follow-up care should be adapted to the individual risk and enable those affected to make a self-determined decision about cryopreservation of germ cells or germ cell tissue. Hyopgonadotropic hypogonadism can be treated by the pulsatile administration of gonadotropins. Affected individuals can be reassured. A health restriction of the offspring due to the cancer treatment is not to be expected, even after artificial insemination.

Authors with CRIS profile

Matthias Beckmann Lehrstuhl für Geburtshilfe und Frauenheilkunde Ralf Dittrich Professur für Experimentelle Reproduktionsmedizin Laura Lotz Professur für Experimentelle Reproduktionsmedizin

Involved external institutions

Charité - Universitätsmedizin Berlin DE Germany (DE) Vivantes - Netzwerk für Gesundheit GmbH DE Germany (DE)

How to cite

APA:

Borgmann-Staudt, A., Jantke, A., Hinz, S., Beckmann, M., Dittrich, R., Lotz, L., & Balcerek, M. (2023). S1 Guideline: Impairment of gonadal function after Cancer in Childhood and Adolescence. Klinische Pädiatrie. https://doi.org/10.1055/a-2081-0605

MLA:

Borgmann-Staudt, Anja, et al. "S1 Guideline: Impairment of gonadal function after Cancer in Childhood and Adolescence." Klinische Pädiatrie (2023).

BibTeX: Download